An Investigation into the Potential of Targeting Escherichia coli rne mRNA with Locked Nucleic Acid (LNA) Gapmers as an Antibacterial Strategy. (2021)
Attributed to:
sRNA-based therapeutics for disease caused by A. pleuropneumoniae
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/molecules26113414
PubMed Identifier: 34200016
Publication URI: http://europepmc.org/abstract/MED/34200016
Type: Journal Article/Review
Volume: 26
Parent Publication: Molecules (Basel, Switzerland)
Issue: 11
ISSN: 1420-3049